Chemoprevention of pulmonary carcinogenesis by myo-inositol

Authors
Citation
Lw. Wattenberg, Chemoprevention of pulmonary carcinogenesis by myo-inositol, ANTICANC R, 19(5A), 1999, pp. 3659-3661
Citations number
24
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
19
Issue
5A
Year of publication
1999
Pages
3659 - 3661
Database
ISI
SICI code
0250-7005(199909/10)19:5A<3659:COPCBM>2.0.ZU;2-V
Abstract
This abstract summarizes material presented at the "First International Sym posium on Disease Prevention by IP6 and other Rice Components "held in Kyot o, Japan in June, I 998. The presentation deals primarily with studies of c hemoprevention of pulmonary carcinogenesis by myo-inositol. This compound i s largely formed by the dephosphorylation of inositol hexaphosphate (IP6, p hytate) within the gastrointestinal tract ill humans and animals. myo-Inosi tol is one of a relatively few compounds that has an inhibitor); effect on carcinogenesis of the lung in experimental animals when administered during the post-initiation period. It prevents pulmonary adenoma formation in A/J mice when fed in the diet subsequent to administrations of benzo[a]pyrene or the tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-bu tanone(NNK) to the mice. A second compound, dexamethasone, also prevents pu lmonary neoplasia under the same conditions. Experiments in which both myo- inositol and dexamethasone were administered together in the diet showed an additive inhibitory effect. The significance and utility of the chemopreve ntive properties of these agents remains to be determined.